Potential buy before more downside.Potential buy before more downside.
Head and shoulders forming for further downside.
4DMedical Ltd.
No trades
No trades
Compare with 4DMedical Ltd.
−0.40 AUD
−204.44 M AUD
7.06 M AUD
502.30 M
Last report date
Aug 28, 2026
Report period
H2 2026
EPS
0.23 AUD
Revenue
4.20 M AUD
Company info
Sector
Industry
CEO
Andreas Fouras
Website
Headquarters
Carlton
Founded
2012
IPO date
Aug 7, 2020
ISIN
AU0000095416
FIGI
BBG00VSFDKL5
Identifiers
ISIN AU0000095416
4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. It develops pipeline products that may assist physicians to more effectively diagnose and manage patients with lung disease, which includes XV ventilation analysis, ventilation perfusion, contrast free pulmonary angiography, small animal ventilator, and preclinical scanner. The company was founded by Andreas Fouras in December 2012 and is headquartered in Carlton, Australia.
Bullish ReversalPretty clear the downtrend has been broken and I'm of the belief that this is currently a bullish retracement (working on wave 2) - Overall this will end up being a long term swing for months/years if I'm correct.
Long
4DXNEWS CAT
1JUL "4DMedical signs deal to supply lung imaging technology to Australian radiology clinics"
Looking for Option A
Or
Looking for Option B
Option B would provide a nice entry if we could flush down into that lower TF range in Blue. This range was the last range on the 5 minute chart tha
Long
4DX - Buying Opportunity4DX has broken its downtrend line with force and high volume, indicating a change in trend. Any retracement lower could be a very good buying opportunity. I expect price to test its support or any retracement lower could be a good opportunity to buy. My Buy Zone is between $1.500 - $1.550, where I w
Long
$4DX another tl break and news. Or is it the other way round.Big day out fo the kid. Well done buyers and sellerts.
Classic setup for the scrap book that one. Ta AT.
Long
$4DX - loves a contraction. $2.45 pot. buy pointThis one looks like it needs a little flag around this 2.40/2.45 level before it can take at that $2.44 supply area.
Love new listings.
Long
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of 4DX is 3.60 AUD — it has increased by 4.65% in the past 24 hours. Watch 4DMedical Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange 4DMedical Ltd. stocks are traded under the ticker 4DX.
4DX stock has fallen by −2.70% compared to the previous week, the month change is a −17.43% fall, over the last year 4DMedical Ltd. has showed a 185.71% increase.
We've gathered analysts' opinions on 4DMedical Ltd. future price: according to them, 4DX price has a max estimate of 6.00 AUD and a min estimate of 3.00 AUD. Watch 4DX chart and read a more detailed 4DMedical Ltd. stock forecast: see what analysts think of 4DMedical Ltd. and suggest that you do with its stocks.
4DX stock is 7.31% volatile and has beta coefficient of 2.08. Track 4DMedical Ltd. stock price on the chart and check out the list of the most volatile stocks — is 4DMedical Ltd. there?
Today 4DMedical Ltd. has the market capitalization of 2.17 B, it has decreased by −10.24% over the last week.
Yes, you can track 4DMedical Ltd. financials in yearly and quarterly reports right on TradingView.
4DMedical Ltd. is going to release the next earnings report on Feb 26, 2027. Keep track of upcoming events with our Earnings Calendar.
4DX earnings for the last half-year are 0.23 AUD per share, whereas the estimation was −0.04 AUD, resulting in a 666.08% surprise. The estimated earnings for the next half-year are −0.04 AUD per share. See more details about 4DMedical Ltd. earnings.
4DMedical Ltd. revenue for the last half-year amounts to 4.20 M AUD, despite the estimated figure of 7.58 M AUD. In the next half-year revenue is expected to reach 8.90 M AUD.
4DX net income for the last half-year is −50.30 M AUD, while the previous report showed −154.14 M AUD of net income which accounts for 0.00% change. Track more 4DMedical Ltd. financial stats to get the full picture.
No, 4DX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 4DMedical Ltd. EBITDA is −52.00 M AUD, and current EBITDA margin is −736.40%. See more stats in 4DMedical Ltd. financial statements.
Like other stocks, 4DX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 4DMedical Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 4DMedical Ltd. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 4DMedical Ltd. stock shows the buy signal. See more of 4DMedical Ltd. technicals for a more comprehensive analysis.